Quinolone action against human topoisomerase IIalpha: stimulation of enzyme-mediated double-stranded DNA cleavage.

Bromberg KD, Burgin AB, Osheroff N
Biochemistry. 2003 42 (12): 3393-8

PMID: 12653542 · DOI:10.1021/bi027383t

Several important antineoplastic drugs kill cells by increasing levels of topoisomerase II-mediated DNA breaks. These compounds act by two distinct mechanisms. Agents such as etoposide inhibit the ability of topoisomerase II to ligate enzyme-linked DNA breaks. Conversely, compounds such as quinolones have little effect on ligation and are believed to stimulate the forward rate of topoisomerase II-mediated DNA cleavage. The fact that there are two scissile bonds per double-stranded DNA break implies that there are two sites for drug action in every enzyme-DNA cleavage complex. However, since agents in the latter group are believed to act by locally perturbing DNA structure, it is possible that quinolone interactions at a single scissile bond are sufficient to distort both strands of the double helix and generate an enzyme-mediated double-stranded DNA break. Therefore, an oligonucleotide system was established to further define the actions of topoisomerase II-targeted drugs that stimulate the forward rate of DNA cleavage. Results indicate that the presence of the quinolone CP-115,953 at one scissile bond increased the extent of enzyme-mediated scission at the opposite scissile bond and was sufficient to stimulate the formation of a double-stranded DNA break by human topoisomerase IIalpha. These findings stand in marked contrast to those for etoposide, which must be present at both scissile bonds to stabilize a double-stranded DNA break [Bromberg, K. D., et al. (2003) J. Biol. Chem. 278, 7406-7412]. Moreover, they underscore important mechanistic differences between drugs that enhance DNA cleavage and those that inhibit ligation.

MeSH Terms (22)

Amino Acid Substitution Anti-Infective Agents Antigens, Neoplasm Antineoplastic Agents Base Sequence Binding Sites Catalytic Domain DNA DNA-Binding Proteins DNA Damage DNA Repair DNA Topoisomerases, Type II Enzyme Activation Etoposide Fluoroquinolones Humans In Vitro Techniques Kinetics Models, Biological Oligodeoxyribonucleotides Recombinant Proteins Substrate Specificity

Connections (1)

This publication is referenced by other Labnodes entities: